James Butler

SonoVol (United States)

Papers

1

Total Citations

18

H-Index

1

About

Dr. James Butler is pioneering the next generation of preclinical imaging technologies, with a focused expertise in developing noninvasive ultrasound platforms for in vivo small-animal studies. His most-cited work, "A new preclinical ultrasound platform for widefield 3D imaging of rodents" (2018, 18 citations), introduces a transformative tool that enables researchers to capture high-resolution, three-dimensional anatomical and functional data from living rodents without surgical intervention. This innovation allows for the longitudinal tracking of disease progression—from tumor growth to cardiac dysfunction—in near real-time, dramatically reducing the number of animals needed per study while increasing data richness. Butler’s contributions bridge a critical gap between clinical ultrasound and benchtop microscopy, offering a scalable, cost-effective solution for preclinical drug screening and basic biology. His platform has been adopted by multiple laboratories seeking to visualize dynamic biological events, such as vascular remodeling and immune cell trafficking, with unprecedented clarity. By making widefield 3D imaging accessible, Butler is accelerating the translation of preclinical findings into clinical applications, positioning himself as a key innovator in the field of biomedical imaging.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
A new preclinical ultrasound platform for widefield 3D imaging of rodents
18 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: SonoVol (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago